Cite
HARVARD Citation
Tanaka, K. et al. (2015). EGFR Mutation Impact on Definitive Concurrent Chemoradiation Therapy for Inoperable Stage III Adenocarcinoma. Journal of thoracic oncology. 10 (12), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tanaka, K. et al. (2015). EGFR Mutation Impact on Definitive Concurrent Chemoradiation Therapy for Inoperable Stage III Adenocarcinoma. Journal of thoracic oncology. 10 (12), p. . [Online].